NEU 2.81% $18.65 neuren pharmaceuticals limited

Share Price

  1. 2,320 Posts.
    lightbulb Created with Sketch. 1963
    I think the current share price is ridiculous for the following reasons .
    1. Current capitalisation of the company is $233 million
    2. The company would have about $35 million in the bank .
    3. So the other assets are valued by the market $198 million ,that is for 6 indications with nnz2566 and nnz2591 .
    4. The trial results for trofinetide should be due in less than 8 weeks .
    5. If trofinetide is successful the share price should be between $4 and $5 dollars.
    6. The results only need to mirror Phase 2 results to be successful .
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.